Vitalhub (TSE:VHI - Get Free Report) was upgraded by investment analysts at National Bank Financial to a "strong-buy" rating in a research report issued on Monday,Zacks.com reports. National Bank Financial also issued estimates for Vitalhub's Q2 2025 earnings at $0.03 EPS, Q3 2025 earnings at $0.05 EPS, Q4 2025 earnings at $0.06 EPS, FY2025 earnings at $0.16 EPS, FY2026 earnings at $0.26 EPS and FY2027 earnings at $0.33 EPS.
A number of other analysts have also recently commented on VHI. National Bankshares set a C$14.00 target price on shares of Vitalhub and gave the stock an "outperform" rating in a research note on Tuesday. TD Securities boosted their target price on shares of Vitalhub from C$13.00 to C$14.00 and gave the company a "buy" rating in a research note on Monday, March 31st. Finally, Raymond James set a C$13.50 price objective on shares of Vitalhub and gave the company an "outperform" rating in a report on Thursday, March 27th. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of C$13.08.
Read Our Latest Stock Report on Vitalhub
Vitalhub Trading Up 1.7%
Shares of Vitalhub stock traded up C$0.19 during trading on Monday, hitting C$11.19. 58,813 shares of the stock traded hands, compared to its average volume of 131,396. Vitalhub has a 52-week low of C$6.74 and a 52-week high of C$12.34. The firm has a market cap of C$605.29 million, a P/E ratio of 182.00, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. The stock's fifty day simple moving average is C$10.37 and its 200 day simple moving average is C$10.62.
Insider Transactions at Vitalhub
In other news, Director Francis Nelson Shen bought 25,000 shares of the firm's stock in a transaction dated Friday, May 16th. The stock was acquired at an average price of C$10.23 per share, for a total transaction of C$255,750.00. Corporate insiders own 18.57% of the company's stock.
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Recommended Stories
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
